Artivion (AORT)
(Delayed Data from NYSE)
$26.60 USD
+0.60 (2.31%)
Updated Jul 11, 2024 04:00 PM ET
After-Market: $26.63 +0.03 (0.11%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth B Momentum C VGM
Price, Consensus and EPS Surprise
AORT 26.60 +0.60(2.31%)
Will AORT be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for AORT based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for AORT
Strength Seen in AxoGen (AXGN): Can Its 5.4% Jump Turn into More Strength?
Artivion, Inc. (AORT) Hit a 52 Week High, Can the Run Continue?
AORT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Artivion (AORT) Tops Q1 Earnings and Revenue Estimates
Is Artivion (AORT) Outperforming Other Medical Stocks This Year?
Artivion, Inc. (AORT) Hits Fresh High: Is There Still Room to Run?
Other News for AORT
Artivion Amends Agreements with Endospan
Artivion (AORT) Receives a Buy from Lake Street
Artivion management to meet with Lake Street
Data-Driven Growth Fuels More Upside For Overlooked Artivion
Artivion management to meet with Lake Street